Pds Biotechnology Corp Stock Operating Margin
| EU6 Stock | EUR 1.10 0.03 2.65% |
PDS Biotechnology Corp fundamentals help investors to digest information that contributes to PDS Biotechnology's financial success or failures. It also enables traders to predict the movement of PDS Stock. The fundamental analysis module provides a way to measure PDS Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PDS Biotechnology stock.
PDS |
PDS Biotechnology Corp Company Operating Margin Analysis
PDS Biotechnology's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, PDS Biotechnology Corp has an Operating Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The operating margin for all Germany stocks is 100.0% lower than that of the firm.
PDS Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PDS Biotechnology's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PDS Biotechnology could also be used in its relative valuation, which is a method of valuing PDS Biotechnology by comparing valuation metrics of similar companies.PDS Biotechnology is currently under evaluation in operating margin category among its peers.
PDS Fundamentals
| Return On Equity | -0.49 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | 189.69 M | |||
| Shares Outstanding | 28.89 M | |||
| Shares Owned By Insiders | 14.20 % | |||
| Shares Owned By Institutions | 23.77 % | |||
| Price To Earning | 23.42 X | |||
| Price To Book | 5.63 X | |||
| EBITDA | (21.43 M) | |||
| Net Income | (16.92 M) | |||
| Cash And Equivalents | 74.75 M | |||
| Cash Per Share | 2.63 X | |||
| Total Debt | 552.98 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 19.22 X | |||
| Book Value Per Share | 1.65 X | |||
| Cash Flow From Operations | (12.49 M) | |||
| Earnings Per Share | (0.91) X | |||
| Price To Earnings To Growth | (0.29) X | |||
| Target Price | 19.71 | |||
| Number Of Employees | 22 | |||
| Beta | 1.91 | |||
| Market Capitalization | 206 M | |||
| Total Asset | 67.2 M | |||
| Net Asset | 67.2 M |
About PDS Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PDS Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PDS Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PDS Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PDS Stock
When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.